JP2014523857A5 - - Google Patents

Download PDF

Info

Publication number
JP2014523857A5
JP2014523857A5 JP2014508179A JP2014508179A JP2014523857A5 JP 2014523857 A5 JP2014523857 A5 JP 2014523857A5 JP 2014508179 A JP2014508179 A JP 2014508179A JP 2014508179 A JP2014508179 A JP 2014508179A JP 2014523857 A5 JP2014523857 A5 JP 2014523857A5
Authority
JP
Japan
Prior art keywords
alkyl
ring
independently
halogen
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014508179A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014523857A (ja
JP6240063B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/035814 external-priority patent/WO2012149540A1/en
Publication of JP2014523857A publication Critical patent/JP2014523857A/ja
Publication of JP2014523857A5 publication Critical patent/JP2014523857A5/ja
Priority to JP2017212845A priority Critical patent/JP6974120B2/ja
Application granted granted Critical
Publication of JP6240063B2 publication Critical patent/JP6240063B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014508179A 2011-04-28 2012-04-30 ヒストンデアセチラーゼ阻害剤 Active JP6240063B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017212845A JP6974120B2 (ja) 2011-04-28 2017-11-02 ヒストンデアセチラーゼ阻害剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161480133P 2011-04-28 2011-04-28
US61/480,133 2011-04-28
PCT/US2012/035814 WO2012149540A1 (en) 2011-04-28 2012-04-30 Inhibitors of histone deacetylase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017212845A Division JP6974120B2 (ja) 2011-04-28 2017-11-02 ヒストンデアセチラーゼ阻害剤

Publications (3)

Publication Number Publication Date
JP2014523857A JP2014523857A (ja) 2014-09-18
JP2014523857A5 true JP2014523857A5 (enExample) 2016-06-09
JP6240063B2 JP6240063B2 (ja) 2017-11-29

Family

ID=47072809

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014508179A Active JP6240063B2 (ja) 2011-04-28 2012-04-30 ヒストンデアセチラーゼ阻害剤
JP2017212845A Active JP6974120B2 (ja) 2011-04-28 2017-11-02 ヒストンデアセチラーゼ阻害剤
JP2019185842A Active JP7042244B2 (ja) 2011-04-28 2019-10-09 ヒストンデアセチラーゼ阻害剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017212845A Active JP6974120B2 (ja) 2011-04-28 2017-11-02 ヒストンデアセチラーゼ阻害剤
JP2019185842A Active JP7042244B2 (ja) 2011-04-28 2019-10-09 ヒストンデアセチラーゼ阻害剤

Country Status (5)

Country Link
US (5) US9365498B2 (enExample)
EP (2) EP2701699B1 (enExample)
JP (3) JP6240063B2 (enExample)
CA (1) CA2834548C (enExample)
WO (1) WO2012149540A1 (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2553337Y2 (ja) 1993-06-30 1997-11-05 住友重機械工業株式会社 電気集塵装置
EP2701699B1 (en) 2011-04-28 2019-10-16 The Broad Institute, Inc. Inhibitors of histone deacetylase
JP6337255B2 (ja) 2012-07-27 2018-06-06 ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. ヒストンデアセチラーゼの阻害剤
WO2014047199A1 (en) * 2012-09-19 2014-03-27 The Research Foundation For The State University Of New York Novel prodrugs for selective anticancer therapy
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
KR20150100814A (ko) 2012-12-21 2015-09-02 콴티셀 파마슈티컬스, 인크. 히스톤 데메틸라제 억제제
US9139583B2 (en) 2013-02-01 2015-09-22 Acetylon Pharmaceuticals, Inc. Selective HDAC3 inhibitors
JP2016511237A (ja) 2013-02-01 2016-04-14 アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 選択的ｈｄａｃ３阻害剤
CN105658643B (zh) * 2013-08-27 2019-03-01 百时美施贵宝公司 Ido抑制剂
NZ728120A (en) 2014-06-25 2023-06-30 Celgene Quanticel Res Inc Histone demethylase inhibitors
WO2015200619A1 (en) * 2014-06-26 2015-12-30 Rodin Therapeutics, Inc. Inhibitors of histone deacetylase
JP6556146B2 (ja) 2014-08-26 2019-08-07 武田薬品工業株式会社 複素環化合物
JP6785801B2 (ja) * 2015-03-06 2020-11-18 コロラド ステート ユニバーシティー リサーチ ファウンデーション 新しいキャップ基ラルガゾールの類似体の合成及び使用
AU2016229324B2 (en) 2015-03-06 2020-01-16 Colorado State University Research Foundation Method for preparing largazole analogs and uses thereof
LT3319959T (lt) * 2015-07-06 2021-12-27 Alkermes, Inc. Histono deacetilazės hetero-halogeno inhibitoriai
WO2017007755A1 (en) * 2015-07-06 2017-01-12 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
WO2017014321A1 (en) 2015-07-17 2017-01-26 Takeda Pharmaceutical Company Limited Oxadiazole derivatives useful as hdac inhibitors
WO2017014170A1 (ja) 2015-07-17 2017-01-26 武田薬品工業株式会社 複素環化合物
US10406146B2 (en) 2015-08-25 2019-09-10 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2017100623A1 (en) 2015-12-09 2017-06-15 Brandeis University Dbh inhibitors for treating or preventing memory loss
RU2018126187A (ru) * 2015-12-17 2020-01-20 Массачусетс Инститьют Оф Текнолоджи Композиции полигидроксилированных бензофенонов и способы лечения нейродегенеративных расстройств
MX386258B (es) 2016-07-01 2025-03-18 Pfizer Derivados de 5,7-dihidro-pirrolo-piridina para tratar enfermedades neurologicas y neurodegenerativas
US10894768B2 (en) 2016-08-26 2021-01-19 Dong-A St Co., Ltd. Salt of (R)-(1-methylpyrrolidine-3-yl)methyl(3′-chloro-4′-fluoro-[1,1′-biphenyl]-2-yl)carbamate and crystal form thereof
KR102239776B1 (ko) * 2016-08-26 2021-04-13 동아에스티 주식회사 (r)-(1-메틸피롤리딘-3-일)메틸(3'-클로로-4'-플루오로-[1,1'-비페닐]-2-일)카바메이트의 신규염 및 이의 결정형
US10793567B2 (en) * 2017-01-11 2020-10-06 Rodin Therapeutics, Inc. Bicyclic inhibitors of histone deacetylase
JP7442439B2 (ja) 2017-03-30 2024-03-04 アルベルト－ルートヴィヒ－ユニバーシティー フライブルク Ｋｄｍ４阻害剤
EP3661931A1 (en) 2017-07-31 2020-06-10 Takeda Pharmaceutical Company Limited Heterocyclic compound
EA039417B1 (ru) 2017-08-07 2022-01-25 Родин Терапеутикс, Инк. Бициклические ингибиторы гистондеацетилазы
EP3664789B1 (en) 2017-08-09 2023-11-22 Children's Hospital Medical Center Methods for treating diseases and nerve injury
EA037772B1 (ru) * 2017-09-07 2021-05-20 Родин Терапеутикс, Инк. Бициклические ингибиторы деацетилазы гистонов
KR20190043437A (ko) 2017-10-18 2019-04-26 씨제이헬스케어 주식회사 단백질 키나제 억제제로서의 헤테로고리 화합물
US12128018B2 (en) 2018-01-12 2024-10-29 KDAc Therapeutics, Inc. Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer
WO2019235501A1 (ja) * 2018-06-06 2019-12-12 塩野義製薬株式会社 ヒストン脱アセチル化酵素阻害剤
EA202190077A1 (ru) * 2018-07-13 2021-08-30 Алкермес, Инк. Ингибиторы гистондеацетилазы
AU2019301761A1 (en) * 2018-07-13 2021-01-14 Alkermes, Inc. Bicyclic inhibitors of histone deacetylase
KR102195348B1 (ko) 2018-11-15 2020-12-24 에이치케이이노엔 주식회사 단백질 키나제 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물
WO2020168241A1 (en) * 2019-02-15 2020-08-20 Flagship Pioneering Inc. X-reactivation modulators and uses thereof
WO2020176513A1 (en) * 2019-02-25 2020-09-03 Emory University Chimeric compounds and methods of managing neurological disorders or conditions
AU2020291460B2 (en) * 2019-06-13 2026-01-29 Dana-Farber Cancer Institute, Inc. HDAC3 catalytic inhibitor development and uses thereof
US20220267323A1 (en) * 2019-07-23 2022-08-25 Alkermes, Inc. Synthesis of bicyclic inhibitors of histone deacetylase
KR20220070465A (ko) 2019-09-27 2022-05-31 다케다 야쿠힌 고교 가부시키가이샤 Hdac6 억제제로서 유용한 2-이소인돌-1,3,4-옥사디아졸 유도체
EP4074700A4 (en) 2019-12-10 2024-02-07 Shionogi & Co., Ltd HISTONE DEACETYLASE INHIBITOR COMPRISING AROMATIC HETEROCYCLIC GROUP CONTAINING NITROGEN
CA3186083A1 (en) 2020-08-14 2022-02-17 Remy LUTHRINGER Condensed azacycles as sigma ligand compounds and uses thereof
JP2023547040A (ja) * 2020-09-24 2023-11-09 エヌフレクション セラピューティクス インコーポレイテッド ピロロピリジン－アニリン化合物による、認知機能不全の処置方法
AU2021410630A1 (en) 2020-12-21 2023-08-03 Cetya Therapeutics, Inc. Synthesis of structural analogs of largazole and associated compounds
CN114957132A (zh) * 2021-02-20 2022-08-30 中国科学院上海药物研究所 含s构型的氨基苯甲酰胺基哒嗪酮类化合物、其制备方法、药物组合物及应用
CN120344242A (zh) * 2022-11-07 2025-07-18 人福医药美国公司 生长抑素受体亚型4(sstr4)激动剂和其应用
WO2024230794A1 (zh) * 2023-05-11 2024-11-14 中国药科大学 氮杂环丁烷衍生物、其制备方法及其医药用途

Family Cites Families (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE670584C (de) * 1936-07-09 1939-01-20 I G Farbenindustrie Akt Ges Verfahren zur Herstellung von o-Aminophenolen
DE1108213B (de) 1959-02-28 1961-06-08 Frantisek Sorm Dr Ing Verfahren zur Herstellung von 2, 2-Dimethyl-3-phenylcyclopropan-carbonsaeuren
SE370866B (enExample) * 1968-03-21 1974-11-04 Ciba Geigy Ag
JPS4825500B1 (enExample) * 1970-12-29 1973-07-30
US3850931A (en) 1971-06-25 1974-11-26 American Home Prod 4-(substituted anilino)-2-phenyl-5-pyrimidinecarboxylic acid esters
GB2079480B (en) 1980-07-08 1984-05-16 Kodak Ltd Heat-activated photographic and thermal recording processes employing precursor compounds
NO156828C (no) * 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
JPS57102887A (en) 1980-12-18 1982-06-26 Otsuka Pharmaceut Co Ltd Preparation of benzo(ij)quinolizine-2-carboxylic acid derivative
US4404356A (en) 1981-09-09 1983-09-13 Ciba-Geigy Corporation Heat-curable epoxide resin compositions
JPS5853916A (ja) 1981-09-09 1983-03-30 チバ−ガイギ−・アクチエンゲゼルシヤフト 熱硬化性エポキシド樹脂組成物
US5525727A (en) 1982-05-18 1996-06-11 University Of Florida Brain-specific drug delivery
DE3511110A1 (de) * 1985-03-27 1986-10-02 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pyridazinone, ihre herstellung und diese verbindungen enthaltende arzneimittel
GB8508588D0 (en) 1985-04-02 1985-05-09 Akzo Nv Indene & napthalene derivatives
NZ219974A (en) 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
IT1231413B (it) * 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
US5994392A (en) 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
DE3830054A1 (de) 1988-09-03 1990-03-15 Boehringer Mannheim Gmbh Phenylamide - verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
JPH03232868A (ja) * 1990-02-05 1991-10-16 Nippon Telegr & Teleph Corp <Ntt> 新規光学活性化合物及び液晶組成物
US5177064A (en) 1990-07-13 1993-01-05 University Of Florida Targeted drug delivery via phosphonate derivatives
AU643141B2 (en) 1991-03-15 1993-11-04 Amgen, Inc. Pulmonary administration of granulocyte colony stimulating factor
JPH06122669A (ja) 1991-12-28 1994-05-06 Ishihara Sangyo Kaisha Ltd ジアミノベンゼン誘導体を含有するホスホリパーゼａ２阻害剤
DE4323916A1 (de) * 1993-07-16 1995-01-19 Basf Ag Substituierte 2-Phenylpyridine
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
EP0809492A4 (en) * 1995-02-17 2007-01-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
US5635503A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Company Dihydropyridine npy antagonists: piperazine derivatives
US5855887A (en) 1995-07-25 1999-01-05 The Regents Of The University Of California Blockade of lymphocyte down-regulation associated with CTLA-4 signaling
US5811097A (en) 1995-07-25 1998-09-22 The Regents Of The University Of California Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
US6051227A (en) 1995-07-25 2000-04-18 The Regents Of The University Of California, Office Of Technology Transfer Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
JPH09227495A (ja) * 1996-02-16 1997-09-02 Tanabe Seiyaku Co Ltd フェノール誘導体及びその製法
WO1999000121A1 (en) 1997-06-26 1999-01-07 Eli Lilly And Company Antithrombotic agents
EE05627B1 (et) 1998-12-23 2013-02-15 Pfizer Inc. CTLA-4 vastased inimese monoklonaalsed antikehad
JP4390024B2 (ja) 1999-04-23 2009-12-24 アステラス製薬株式会社 新規なジアゼパン誘導体又はその塩
US6653309B1 (en) 1999-04-26 2003-11-25 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme technical field of the invention
NZ517202A (en) 1999-08-24 2004-05-28 Medarex Inc Human CTLA-4 antibodies and their uses
US7605238B2 (en) 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
US6713454B1 (en) 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs
EP1261376A1 (en) 2000-01-27 2002-12-04 Genetics Institute, LLC Antibodies against ctla4(cd152), conjugates comprising same, and uses thereof
FR2805741B1 (fr) * 2000-03-06 2003-06-20 Oreal Composition de teinture d'oxydation des fibres keratiniques avec un derive particulier de la paraphenylenediamine et un colorant direct particulier
EP1280764B1 (en) * 2000-03-24 2010-11-24 Methylgene, Inc. Inhibitors of histone deacetylase
DE10038007A1 (de) * 2000-08-04 2002-02-14 Bayer Ag Neue Amino-und Amido-Diphenylether für Arzneimittel
US20020173507A1 (en) 2000-08-15 2002-11-21 Vincent Santora Urea compounds and methods of uses
US6645990B2 (en) * 2000-08-15 2003-11-11 Amgen Inc. Thiazolyl urea compounds and methods of uses
ATE448306T1 (de) 2000-09-01 2009-11-15 Blood Res Center Veränderte, in gewünschter konformation stabilisierte polypeptide und verfahren zu deren herstellung
WO2002046172A2 (en) 2000-12-07 2002-06-13 Cv Therapeutics, Inc. Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
JP4183923B2 (ja) 2001-03-29 2008-11-19 富士フイルム株式会社 熱現像感光材料
CA2442557C (en) * 2001-04-12 2008-12-23 F. Hoffmann-La Roche Ag Dihydro-benzo¬b|¬1,4|diazepin-2-one derivatives as mglur2 antagonists ii
AR034897A1 (es) * 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
US6949542B2 (en) 2002-02-06 2005-09-27 Hoffman-La Roche Inc. Dihydro-benzo[b][1,4]diazepin-2-one derivatives
TWI319387B (en) 2002-04-05 2010-01-11 Astrazeneca Ab Benzamide derivatives
IL164287A0 (en) 2002-04-12 2005-12-18 Medarex Inc Methods of treatment using ctla-4 antibodies
EP1402888A1 (en) * 2002-09-18 2004-03-31 Jerini AG The use of substituted carbocyclic compounds as rotamases inhibitors
US7244751B2 (en) 2003-02-14 2007-07-17 Shenzhen Chipscreen Biosciences Ltd. Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
BRPI0407587A (pt) 2003-02-18 2006-02-14 Pfizer inibidores do vìrus da hepatite c, composições e tratamentos que os utilizam
WO2005025557A1 (en) 2003-09-16 2005-03-24 Monash University An agent for plasminogen-activation and matrix metalloproteinase associated conditions and methods of use
WO2005030704A1 (en) 2003-09-24 2005-04-07 Methylgene, Inc. Inhibitors of histone deacetylase
EP1687513B1 (en) 2003-10-02 2010-12-22 Jesel, Inc. Double roller cam follower
WO2005034880A2 (en) 2003-10-09 2005-04-21 Aton Pharma, Inc. Thiophene and benzothiophene hydroxamic acid derivatives
US20080070954A1 (en) 2003-10-27 2008-03-20 S*Bio Pte Ltd. Acylurea Connected And Sulfonylurea Connected Hydroxamates
WO2005066151A2 (en) 2003-12-19 2005-07-21 Takeda San Diego, Inc. Histone deacetylase inhibitors
WO2006001958A2 (en) 2004-05-21 2006-01-05 Merck & Co., Inc. Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
US20060008517A1 (en) 2004-07-09 2006-01-12 Lynch Marina A Treatment of age-related memory impairment
CN101001851B (zh) 2004-08-09 2011-04-20 安斯泰来制药有限公司 具有作为组蛋白脱乙酰酶(hdac)抑制剂的活性的羟基酰胺化合物
JPWO2006028161A1 (ja) * 2004-09-09 2008-05-08 財団法人乙卯研究所 セロトニン５−ｈｔ３受容体作動薬
EP1896395B1 (en) 2005-06-24 2015-07-15 Merck Sharp & Dohme Corp. Modified malonate derivatives
EA019344B1 (ru) 2005-07-01 2014-03-31 МЕДАРЕКС, Эл.Эл.Си. Человеческие моноклональные антитела против лиганда-1 запрограммированной гибели клеток (pd-l1) и их применения
AU2007208495A1 (en) 2006-01-12 2007-08-02 Merck Sharp & Dohme Corp. Hydroxyalkylarylamide derivatives
WO2007118137A1 (en) * 2006-04-07 2007-10-18 Methylgene Inc. Benzamide derivatives as inhibitors of histone deacetylase
EP2121626A1 (en) 2006-12-15 2009-11-25 Pfizer Products Inc. Benzimidazole derivatives
EP2099771A1 (en) 2006-12-19 2009-09-16 Genentech, Inc. Pyrimidine kinase inhibitors
CA2673870A1 (en) 2006-12-27 2008-07-10 Emory University Compositions and methods for the treatment of infections and tumors
CN101730703B (zh) 2007-03-16 2012-12-26 中国人民解放军军事医学科学院放射与辐射医学研究所 具有抗增殖活性的苯甲酰胺类衍生物及其药用制剂
JP5191537B2 (ja) 2007-06-18 2013-05-08 エム・エス・ディー・オス・ベー・フェー ヒトのプログラムされたデスレセプターｐｄ−１に対する抗体
WO2009002534A1 (en) 2007-06-26 2008-12-31 Gilead Colorado, Inc. Imidazopyridinyl thiazolyl histone deacetylase inhibitors
US8389553B2 (en) * 2007-06-27 2013-03-05 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
US8138168B1 (en) * 2007-09-26 2012-03-20 Takeda Pharmaceutical Company Limited Renin inhibitors
MX2010004402A (es) 2007-10-22 2010-10-15 Orchid Res Lab Ltd Inhibidores de histona deacetilasa.
EP2217588A4 (en) 2007-11-02 2013-12-04 Methylgene Inc INHIBITORS OF HISTONE DEACETYLASE
WO2009076234A2 (en) 2007-12-07 2009-06-18 University Of Maryland, Baltimore Synthesis methods of histone deacetylase inhibitors (hdacis)
US8138138B2 (en) 2008-01-04 2012-03-20 Ecolab Usa Inc. Solidification matrix using a polycarboxylic acid polymer
UA103018C2 (uk) 2008-02-22 2013-09-10 Оцука Фармасьютікал Ко., Лтд. Сполуки бензодіазепіну і фармацевтична композиція
US8093000B2 (en) 2008-05-09 2012-01-10 The Regents Of The University Of California Methods for predicting and treating tumors resistant to drug, immunotherapy, and radiation
WO2010009139A2 (en) 2008-07-14 2010-01-21 Gilead Colorado, Inc. Imidazolyl pyrimidine inhibitor compounds
US20110178138A1 (en) 2008-07-28 2011-07-21 The Regents Of The University Of California Inhibitors of protein prenyltransferases
US8119129B2 (en) 2008-08-01 2012-02-21 Bristol-Myers Squibb Company Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases
RS54233B1 (sr) 2008-08-25 2015-12-31 Amplimmune Inc. Kompozicije pd-1 antagonista i postupci za njihovu primenu
CA2735593C (en) 2008-09-03 2017-08-15 Repligen Corporation Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
BRPI0919377A2 (pt) 2008-09-26 2016-09-27 Dana Farber Cancer Inst Inc anticorpo isolado ou um fragmento ligante de antígeno do memso, ácido nucleico isolado, vetor, célula hospedeira, composição farmacêutica, método de produzir o referido anticorpo ou fragmento, uso dos mesmos, e composição compreendendo o referido anticorpo ou fragmento
WO2010042433A1 (en) 2008-10-06 2010-04-15 Bristol-Myers Squibb Company Combination of cd137 antibody and ctla-4 antibody for the treatment of proliferative diseases
US8232409B2 (en) * 2008-10-15 2012-07-31 Janssen Pharmaceutica N.V. Heterocyclic benzimidazoles as TRPM8 modulators
NZ593447A (en) 2008-12-03 2012-12-21 Harvard College Inhibition of hdac2 to promote memory
HUE065752T2 (hu) 2008-12-09 2024-06-28 Hoffmann La Roche Anti-PD-L1 antitestek és felhasználásuk T-sejt funkció elõsegítésére
ES2629337T3 (es) 2009-02-09 2017-08-08 Inserm - Institut National De La Santé Et De La Recherche Médicale Anticuerpos contra PD-1 y anticuerpos contra PD-L1 y usos de los mismos
WO2010094678A1 (en) * 2009-02-23 2010-08-26 F. Hoffmann-La Roche Ag Novel ortho-aminoamides for the treatment of cancer
US8211901B2 (en) 2009-05-22 2012-07-03 Shenzhen Chipscreen Biosciences Ltd. Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
CN102459249A (zh) * 2009-05-22 2012-05-16 埃克塞里艾克西斯公司 作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法
CN102803246A (zh) 2009-06-11 2012-11-28 锡耶纳生物技术股份公司 Hedgehog途径拮抗剂及其治疗应用
JP2012533569A (ja) * 2009-07-16 2012-12-27 ヴァーテックス ファーマシューティカルズ、 インコーポレイテッド フラビウイルス感染症を治療又は予防するためのベンゾイミダゾール類似体
IN2012DN03807A (enExample) * 2009-10-30 2015-08-28 Massachusetts Inst Technology
EP2504028A4 (en) 2009-11-24 2014-04-09 Amplimmune Inc SIMULTANEOUS INHIBITION OF PD-L1 / PD-L2
US8952037B2 (en) * 2010-05-13 2015-02-10 Amgen Inc. Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
US20140107166A1 (en) 2011-02-14 2014-04-17 Dana-Farber Cancer Institute, Inc. Histone deacetylase inhibitors and methods of use thereof
RU2013140975A (ru) 2011-02-28 2015-04-10 Дженентек, Инк. Биологические маркеры и способы прогнозирования восприимчивости к антагонистам в-клеток
EP3524324A1 (en) 2011-02-28 2019-08-14 BioMarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
EP2701699B1 (en) 2011-04-28 2019-10-16 The Broad Institute, Inc. Inhibitors of histone deacetylase
CN102775356B (zh) 2011-05-13 2015-07-22 江苏恒谊药业有限公司 4-氨基喹唑啉衍生物及其应用
US20130071403A1 (en) 2011-09-20 2013-03-21 Vical Incorporated Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
WO2013059582A2 (en) 2011-10-20 2013-04-25 Nupotential, Inc. Small molecule inhibitors of histone deacteylases
EP2773653A4 (en) 2011-11-02 2015-08-05 Broad Inst Inc FLUORESCENT SUBSTRATES FOR DETERMINING THE ACTIVITY OF A LYSIN-MODIFYING ENZYME
CA2759407A1 (en) 2011-12-02 2013-06-02 Marrett Alexander GREEN Grey water recycling systems and valves
CN104159911A (zh) 2012-03-07 2014-11-19 奥瑞基尼探索技术有限公司 作为免疫调节剂的模拟肽化合物
US9212224B2 (en) 2012-05-15 2015-12-15 Bristol-Myers Squibb Company Antibodies that bind PD-L1 and uses thereof
JP6337255B2 (ja) 2012-07-27 2018-06-06 ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. ヒストンデアセチラーゼの阻害剤
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
US9988343B2 (en) 2013-11-05 2018-06-05 Dana-Farber Cancer Institute, Inc. Inhibitors of histone deacetylase
EP3114109A4 (en) 2014-03-07 2017-10-18 The Johns Hopkins University Inhibitors of histone lysine specific demethylase (lsd1) and histone deacetylases (hdacs)
UY36351A (es) 2014-10-14 2016-06-01 Novartis Ag Moléculas de anticuerpo que se unen a pd-l1 y usos de las mismas
CN115925939A (zh) 2015-08-06 2023-04-07 新加坡科技研究局 IL2Rβ/通用γ链抗体
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
US12440451B2 (en) 2017-01-10 2025-10-14 Dana-Farber Cancer Institute, Inc. Compositions and methods using an epigenetic inhibitor
US12128018B2 (en) 2018-01-12 2024-10-29 KDAc Therapeutics, Inc. Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2014523857A5 (enExample)
JP2019081762A5 (enExample)
JP2015535277A5 (enExample)
JP2016531868A5 (enExample)
CO2018004800A2 (es) Antagonistas del receptor muscarinico 4 y metodos de uso.
AR105113A1 (es) Compuestos de aminopiridina sustituida con heteroarilo
AR104447A1 (es) Azabenzimidazoles y sus usos como moduladores de los receptores ampa
JP2016532673A5 (enExample)
JP2016516706A5 (enExample)
JP2017530959A5 (enExample)
WO2016063294A3 (en) Process for the preparation of (r)-3-(4-(7h-pyrrolo[2,3-d], pyrimidin-4-yl)-1 h-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate and its polymorphs thereof
AR112264A1 (es) Derivados de oxoftalazina y oxocinolina como antagonistas de los receptores s1p, composición farmacéutica que los comprende y su uso para el tratamiento de enfermedades fibróticas, autoinmunes y proliferativas
JP2016531858A5 (enExample)
AR099955A1 (es) Compuestos de heteroarilo o arilo bicíclicos fusionados
MX2017008417A (es) Procedimientos para preparar inhibidores de cinasa 1 reguladora de señal de apoptosis (ask1).
AR105114A1 (es) Compuestos de aminopiridina sustituida con heteroarilo
AR090587A1 (es) Compuestos triciclicos sustituidos con actividad hacia los receptores ep1
MX2015012629A (es) Compuestos de imidazo piridina.
SI3102573T1 (en) SUBSTITUTED TIAZOL OR OXASOL AS ANTAGONISTS OF THE RECEPTOR P2X7
AR092973A1 (es) Benzamidas
RU2018114460A (ru) 4-амино-6-(4-замещенные-фенил)-пиколинаты и 6-амино-2-(4-замещенные-фенил)-пиримидин-4-карбоксилаты и их применение в качестве гербицидов
JOP20170101B1 (ar) توليف مركبات إندازول
AR106522A1 (es) Intermediarios para preparar herbicidas de piridazinona, y un proceso para prepararlos
AR102539A1 (es) Triazolo[4,5-d]pirimidinas
HK1201534A1 (en) Pharmaceutical compounds